Physician

Abhishek Sripad, MD

According to 2025 Medicare claims, Abhishek Sripad, MD (NPI: 1770961401) practices obstetrics/gynecology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (NPI: 1780669200; TIN: 561732213) and primary practice location at 27607-7510. Sripad is affiliated with the CVS ACO (ACO ID: A5407) and CHESS Genesis, LLC (ACO ID: D0237), participating under both the MSSP and REACH models.

Sripad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 272 traditional Medicare patients, billed 3,002 HCPCS/CPT codes, and received $96,234 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 431 prescription claims across 166 beneficiaries totaling $140,878 in drug costs, led by Gemtesa (Vibegron). Open Payments data shows 2 records totaling $55. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,918 to $140,878. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$57K$114K2022 Medicare payment: $29,719 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $114,273 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $96,234 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202283881$29,719
20232542,898$114,273
20242723,002$96,234

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$70K$141K2016 Drug cost: $2,918 (USD; Tot_Drug_Cst)2017 Drug cost: $2,531 (USD; Tot_Drug_Cst)2018 Drug cost: $2,397 (USD; Tot_Drug_Cst)2019 Drug cost: $9,564 (USD; Tot_Drug_Cst)2020 Drug cost: $49,269 (USD; Tot_Drug_Cst)2021 Drug cost: $60,298 (USD; Tot_Drug_Cst)2022 Drug cost: $42,103 (USD; Tot_Drug_Cst)2023 Drug cost: $116,419 (USD; Tot_Drug_Cst)2024 Drug cost: $140,878 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20162152$2,918
20171943$2,531
20184074$2,397
20195995$9,564
2020143274$49,269
2021147311$60,298
2022136270$42,103
2023210456$116,419
2024166431$140,878

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4848$117
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more136175$82
51798Ultrasound measurement of bladder capacity after voiding4546$8
81001Manual urinalysis test with examination using microscope, automated5159$3
81003Automated urinalysis test99108$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GemtesaVibegron1005,088$81,253
MyrbetriqMirabegron612,670$38,770
EstradiolEstradiol463,333$3,612
Solifenacin SuccinateSolifenacin Succinate211,710$2,251
Trospium ChlorideTrospium Chloride311,410$1,013

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$55Axonics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abhishek Sripad, MD?

Tedicare shows public-source Medicare data for Abhishek Sripad, MD (NPI 1770961401), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhishek Sripad, MD have ACO affiliation data?

Abhishek Sripad, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407) and CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Abhishek Sripad, MD?

Abhishek Sripad, MD is linked to UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (billing NPI 1780669200) in the available physician profile data.

Does Abhishek Sripad, MD have Open Payments data?

Abhishek Sripad, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.